pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-451b |
Genomic Coordinates | chr17: 28861371 - 28861438 |
Description | Homo sapiens miR-451b stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-451b | ||||||||||||||
Sequence | 7| UAGCAAGAGAACCAUUACCAUU |28 | ||||||||||||||
Evidence | Experimental | ||||||||||||||
Experiments | Illumina | ||||||||||||||
Editing Events in miRNAs |
|
||||||||||||||
SNPs in miRNA |
|
||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | USP14 | ||||||||||||||||||||
Synonyms | TGT | ||||||||||||||||||||
Description | ubiquitin specific peptidase 14 | ||||||||||||||||||||
Transcript | NM_001037334 | ||||||||||||||||||||
Other Transcripts | NM_005151 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on USP14 | |||||||||||||||||||||
3'UTR of USP14 (miRNA target sites are highlighted) |
>USP14|NM_001037334|3'UTR 1 TCTTCATTTTAGTATTTATGCTTAGATGTGAAAATAAATGTTATTTGTTGATCATTTCTATAATCCAGAGCTTTAGAGGA 81 AGACACATAGGTGGGTTTATGTTTCACCTCATTTGGAACAAAAGAGGACAGAAGCAGACCACTCTGTGCACCAACCTAAA 161 AAATTACAGAGAAGAGAAAATTATCTTTGGATTGTGCTGCCCTATATAAAGGTGGCAGAAAGACATTTTTAAAAAGCTTA 241 TTATTTCTTGCATTATTTTAAAAAGTTCAGAGTTGAAATGCCTTTCAACCATTTCCTTCTGTGGTCATTTTTCTTGCTGC 321 CTTTTTCACCCAAGATTCAGCAGTCAGATGTTTACTGCACACCTATTACCTATTATTTGCTGTTCTTGCATGGTTCAAAC 401 CACCATTCTGTAGCCACCCATCCTTTGCCTTATCTAACAAACATTTTTCCAGGAAGGTGGAAAAGGAAGTGTTGCTCTCA 481 TTGTGTGACTCAGTGCTGCTGTCCATCCCATGGAAACATGGGCACAATCAAGTATTTGTCCAGCCTATTGCAGGCTTTTC 561 CTGACTTTAAAATAAATTGTGATCAATAATAGTACCTTTGATTATACATTTATTATTGTGTCTCTCTCTGATGTACTGTG 641 GATTGTACATTTAACTTTGGAATGGCTTTGTAATAATCAGTCTTAAGAAAATGTTGACAAGCTCTGGTTGCTTATTTTTA 721 GAAAATGAGGACATTTAATAATAATAAAAAAAAAGGGATTAATAGCTTTTGACCTCAAGTCTTTTGTCTTCTGAGTGTTG 801 GAGCTTGGCTGAAGACATGTTTAATACTGTACAATTTCTGAAGATGGTTATTAACACTGTGCTGTTAAGCATCCATTTAA 881 AAATATTTGTTATCTTCTTTGCCTGCCTGTATTTTAAAAAGAAATACAAAGTTGTAAAAGTAATGGATTTCTTTGGATGC 961 TGAATGCAGTGATGTTATCAGTCAGATTCTTTCCTTGGCTCAGTTGTGTTTGTATTTCCTTTCTTAATTCCCCAAATCTT 1041 GGCTGGGCACGGTGGCTCACGCCTGTAATCCCAGCACTTTGGGAGGCTGAGGCAGGTGGTTCACTGGAGGTTGAGTTCGA 1121 GACCAGCCTGGCCACATGGTGAAACCCTGTCTCTACTAAAGATATAAAAATTAGCTGGATGTGGTGGTGCACACCTGTGA 1201 TCCCAGCTACTTGGGAGGCTGAGGTGGGAGAATTGCTTGAACCTGGAAGGCAGAAGTTGCAGTGAGCTGAGATCACACCA 1281 CTGCACTCCAGCCTGGGTGACAGAGAGACTCTGTCTCAAAAAAAAAAAGAAAAAATTCCCAAATCTTAATGTCTGTTTCA 1361 GAATTTTAGTGATTTTAAAGTGATAGTAGAAAATACCAAGCATATGAGGTATTTCAATATGATAGGCTTCTTACATTTTA 1441 ATAGTTACTCATCTTTGTTCCAGGACCCTTGACTGATGCTAGGGAAAGGATAAAGCATAGAATACCAGCCAGTTTGGCTC 1521 TGATTTTGAGTTATTTATAATAAAGTTTGGGGATTATCATAACATCTCATATCTTTGTGTATGTTGTTTTAATGCTCGGC 1601 AGAGCACAACACTGATGATAACTATTAAAAATAGAAAATAACAGCCATTTTACTTTCAAATCTGATGTGATGCAATCTGT 1681 GAACACTAGGAGGGGATAAAATAAGCATTGCAGGGAAACTTATTTGTAAATAGCTTCCTCACCTAAACTTTGACTTGGCA 1761 ATCAATACTTTCTACTTTGTGGAGGGGATTAAGAATAGAATGGGCAGGATGAGACCATGAAAATTATAATGATTCATGTA 1841 TATTTGTATGATGCTTGTAACTTTGCAAAGTCTTTTTTATTCATTGTCTCATTTGGTCAGAACAATTTTATTGAGGACAT 1921 GAATTTAACAATTAGAATTTAGATTTTCTGACTGTAGCTACTAAATGTTGTAGCTACTAGACCAGGTGAGCTAGGTTTAG 2001 AGCAAAGTATATAAGCCTTGTATGGACTATATTAGAATTTTAAAAATTGTAATTAATTCCTTATCATCATTATAAAAAGC 2081 TTGATTTTTTTATTTGATCTAAAAAAGCATTATTCCAAAGAATTTTTTCAAGTAGAAATGGGAGTTAGTTATACCAGTGT 2161 TGTTTTTAACTAATAAGGCTATTTTAGAATTCAGCCTTGCCTGTAAGGTCTTTGAGAAGGGAGAGGAGTAGGCCAAAAAA 2241 AAAAAAGTCTTGATTCCTGAATGTGCCTTATATGCTGTGCCACTCACACCGAGGCCATCATCTCAACATTAGAGTTGTGC 2321 TAGATTACTGCTTGACTGACTAGCTAGGTTAGGCCTAAGAGTGTTTACCGAATAATCTGCACTCACTCAGTAGCCCTTCT 2401 TCAGGATTAAAAACGATGATGACCTCATCTTAGAGCCCTAAAGGGAAATGCTTAT Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 9097.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 9097.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | MCF7 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000261601.7 | 3UTR | UCAUUUUUCUUGCUGCCUUUUUCACCCAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000261601.7 | 3UTR | UCAUUUUUCUUGCUGCCUUUUUCACCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000261601.7 | 3UTR | UCAUUUUUCUUGCUGCCUUUUUCACCCAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
124 hsa-miR-451b Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT060018 | VANGL2 | VANGL planar cell polarity protein 2 | 2 | 4 | ||||||||
MIRT069874 | SRP54 | signal recognition particle 54 | 2 | 2 | ||||||||
MIRT088316 | RAB10 | RAB10, member RAS oncogene family | 2 | 4 | ||||||||
MIRT100747 | VEGFA | vascular endothelial growth factor A | 5 | 12 | ||||||||
MIRT152236 | ZNF460 | zinc finger protein 460 | 2 | 2 | ||||||||
MIRT198492 | USP14 | ubiquitin specific peptidase 14 | 2 | 6 | ||||||||
MIRT204750 | BZW1 | basic leucine zipper and W2 domains 1 | 2 | 12 | ||||||||
MIRT211209 | FGF2 | fibroblast growth factor 2 | 2 | 2 | ||||||||
MIRT234352 | MSL1 | male specific lethal 1 homolog | 2 | 8 | ||||||||
MIRT281810 | MAP2K1 | mitogen-activated protein kinase kinase 1 | 2 | 2 | ||||||||
MIRT369113 | CKMT1A | creatine kinase, mitochondrial 1A | 2 | 2 | ||||||||
MIRT401349 | C5ORF51 | chromosome 5 open reading frame 51 | 2 | 4 | ||||||||
MIRT441509 | ERN1 | endoplasmic reticulum to nucleus signaling 1 | 2 | 2 | ||||||||
MIRT441888 | RD3 | retinal degeneration 3 | 2 | 4 | ||||||||
MIRT443549 | GPR35 | G protein-coupled receptor 35 | 2 | 2 | ||||||||
MIRT444959 | ADAM22 | ADAM metallopeptidase domain 22 | 2 | 2 | ||||||||
MIRT445808 | NFATC2 | nuclear factor of activated T-cells 2 | 2 | 2 | ||||||||
MIRT446509 | ASCC1 | activating signal cointegrator 1 complex subunit 1 | 2 | 2 | ||||||||
MIRT447457 | ST18 | ST18, C2H2C-type zinc finger | 2 | 2 | ||||||||
MIRT448296 | ZDHHC3 | zinc finger DHHC-type containing 3 | 2 | 2 | ||||||||
MIRT463178 | ZNF281 | zinc finger protein 281 | 2 | 2 | ||||||||
MIRT466606 | TBC1D13 | TBC1 domain family member 13 | 2 | 2 | ||||||||
MIRT467235 | SPRED1 | sprouty related EVH1 domain containing 1 | 2 | 2 | ||||||||
MIRT471039 | PISD | phosphatidylserine decarboxylase | 2 | 10 | ||||||||
MIRT471892 | NUAK2 | NUAK family kinase 2 | 2 | 2 | ||||||||
MIRT474151 | LIMA1 | LIM domain and actin binding 1 | 2 | 6 | ||||||||
MIRT474155 | LIFR | LIF receptor alpha | 2 | 2 | ||||||||
MIRT481037 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | 2 | 2 | ||||||||
MIRT483083 | GPR75 | G protein-coupled receptor 75 | 2 | 4 | ||||||||
MIRT485208 | PRKAR2A | protein kinase cAMP-dependent type II regulatory subunit alpha | 2 | 8 | ||||||||
MIRT495187 | ST3GAL1 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | 2 | 2 | ||||||||
MIRT495431 | ATG7 | autophagy related 7 | 2 | 2 | ||||||||
MIRT499160 | FAM83C | family with sequence similarity 83 member C | 2 | 6 | ||||||||
MIRT499505 | GGA3 | golgi associated, gamma adaptin ear containing, ARF binding protein 3 | 2 | 2 | ||||||||
MIRT500400 | ZMAT3 | zinc finger matrin-type 3 | 2 | 10 | ||||||||
MIRT500684 | TRIM37 | tripartite motif containing 37 | 2 | 2 | ||||||||
MIRT501301 | RPS6KB1 | ribosomal protein S6 kinase B1 | 2 | 2 | ||||||||
MIRT504339 | ASGR2 | asialoglycoprotein receptor 2 | 2 | 6 | ||||||||
MIRT505931 | RCAN3 | RCAN family member 3 | 2 | 4 | ||||||||
MIRT513196 | SLU7 | SLU7 homolog, splicing factor | 2 | 2 | ||||||||
MIRT521807 | POM121C | POM121 transmembrane nucleoporin C | 2 | 2 | ||||||||
MIRT522779 | LAMP2 | lysosomal associated membrane protein 2 | 2 | 6 | ||||||||
MIRT530179 | ZBED2 | zinc finger BED-type containing 2 | 2 | 2 | ||||||||
MIRT532397 | SNX3 | sorting nexin 3 | 2 | 2 | ||||||||
MIRT532482 | HOXA13 | homeobox A13 | 2 | 2 | ||||||||
MIRT532538 | WDR13 | WD repeat domain 13 | 2 | 2 | ||||||||
MIRT534779 | RAN | RAN, member RAS oncogene family | 2 | 2 | ||||||||
MIRT535719 | N4BP1 | NEDD4 binding protein 1 | 2 | 2 | ||||||||
MIRT539310 | AKAP12 | A-kinase anchoring protein 12 | 2 | 4 | ||||||||
MIRT539877 | RPL32 | ribosomal protein L32 | 2 | 2 | ||||||||
MIRT539891 | IRGQ | immunity related GTPase Q | 2 | 2 | ||||||||
MIRT540063 | CEP104 | centrosomal protein 104 | 2 | 2 | ||||||||
MIRT540154 | GTF2B | general transcription factor IIB | 2 | 4 | ||||||||
MIRT540206 | ARHGAP18 | Rho GTPase activating protein 18 | 2 | 2 | ||||||||
MIRT540391 | CRTC1 | CREB regulated transcription coactivator 1 | 2 | 2 | ||||||||
MIRT540595 | ERCC1 | ERCC excision repair 1, endonuclease non-catalytic subunit | 2 | 4 | ||||||||
MIRT540733 | FABP2 | fatty acid binding protein 2 | 2 | 2 | ||||||||
MIRT540949 | SLC25A43 | solute carrier family 25 member 43 | 2 | 2 | ||||||||
MIRT541444 | C18orf32 | chromosome 18 open reading frame 32 | 2 | 4 | ||||||||
MIRT541571 | ZNF43 | zinc finger protein 43 | 2 | 4 | ||||||||
MIRT541601 | ALOX15 | arachidonate 15-lipoxygenase | 2 | 2 | ||||||||
MIRT541933 | ORC1 | origin recognition complex subunit 1 | 2 | 4 | ||||||||
MIRT542394 | WDR12 | WD repeat domain 12 | 2 | 2 | ||||||||
MIRT542414 | SYNJ2BP | synaptojanin 2 binding protein | 2 | 2 | ||||||||
MIRT542481 | APOC3 | apolipoprotein C3 | 2 | 2 | ||||||||
MIRT542621 | XIAP | X-linked inhibitor of apoptosis | 2 | 2 | ||||||||
MIRT542976 | FAM83F | family with sequence similarity 83 member F | 2 | 2 | ||||||||
MIRT543741 | DHCR7 | 7-dehydrocholesterol reductase | 2 | 2 | ||||||||
MIRT544594 | AP5Z1 | adaptor related protein complex 5 zeta 1 subunit | 2 | 4 | ||||||||
MIRT546441 | SNX5 | sorting nexin 5 | 2 | 2 | ||||||||
MIRT548213 | FKBP1A | FK506 binding protein 1A | 2 | 2 | ||||||||
MIRT550471 | OSCAR | osteoclast associated, immunoglobulin-like receptor | 2 | 4 | ||||||||
MIRT555230 | PRKAA1 | protein kinase AMP-activated catalytic subunit alpha 1 | 2 | 4 | ||||||||
MIRT555428 | PPAP2B | phospholipid phosphatase 3 | 2 | 2 | ||||||||
MIRT556368 | MAF | MAF bZIP transcription factor | 2 | 2 | ||||||||
MIRT558149 | ELK4 | ELK4, ETS transcription factor | 2 | 2 | ||||||||
MIRT566181 | PTPN14 | protein tyrosine phosphatase, non-receptor type 14 | 2 | 2 | ||||||||
MIRT568468 | ARMC12 | armadillo repeat containing 12 | 2 | 2 | ||||||||
MIRT607594 | TANGO2 | transport and golgi organization 2 homolog | 2 | 2 | ||||||||
MIRT617588 | NDUFB5 | NADH:ubiquinone oxidoreductase subunit B5 | 2 | 2 | ||||||||
MIRT621244 | SIGLEC9 | sialic acid binding Ig like lectin 9 | 2 | 4 | ||||||||
MIRT623679 | HOXD4 | homeobox D4 | 2 | 2 | ||||||||
MIRT625989 | FGFR1OP | FGFR1 oncogene partner | 2 | 4 | ||||||||
MIRT627244 | ZBTB3 | zinc finger and BTB domain containing 3 | 2 | 2 | ||||||||
MIRT632946 | ELOVL6 | ELOVL fatty acid elongase 6 | 2 | 4 | ||||||||
MIRT635872 | SLC11A2 | solute carrier family 11 member 2 | 2 | 2 | ||||||||
MIRT636638 | CHAF1B | chromatin assembly factor 1 subunit B | 2 | 2 | ||||||||
MIRT643563 | WDR73 | WD repeat domain 73 | 2 | 2 | ||||||||
MIRT647907 | CIRH1A | UTP4, small subunit processome component | 2 | 2 | ||||||||
MIRT652503 | TMEM170A | transmembrane protein 170A | 2 | 2 | ||||||||
MIRT652843 | TACO1 | translational activator of cytochrome c oxidase I | 2 | 2 | ||||||||
MIRT653299 | SMUG1 | single-strand-selective monofunctional uracil-DNA glycosylase 1 | 2 | 2 | ||||||||
MIRT659383 | CREG2 | cellular repressor of E1A stimulated genes 2 | 2 | 2 | ||||||||
MIRT661339 | TBC1D15 | TBC1 domain family member 15 | 2 | 2 | ||||||||
MIRT662372 | ANKRD42 | ankyrin repeat domain 42 | 2 | 2 | ||||||||
MIRT664322 | CD209 | CD209 molecule | 2 | 2 | ||||||||
MIRT671759 | F11R | F11 receptor | 2 | 2 | ||||||||
MIRT673240 | KLHDC8A | kelch domain containing 8A | 2 | 2 | ||||||||
MIRT682871 | C9orf156 | tRNA methyltransferase O | 2 | 2 | ||||||||
MIRT683171 | SF3A1 | splicing factor 3a subunit 1 | 2 | 2 | ||||||||
MIRT684262 | TBXA2R | thromboxane A2 receptor | 2 | 2 | ||||||||
MIRT684395 | MCTS1 | MCTS1, re-initiation and release factor | 2 | 2 | ||||||||
MIRT684883 | P4HB | prolyl 4-hydroxylase subunit beta | 2 | 2 | ||||||||
MIRT686650 | TMEM184C | transmembrane protein 184C | 2 | 2 | ||||||||
MIRT687771 | KIAA0355 | KIAA0355 | 2 | 2 | ||||||||
MIRT694352 | CHST6 | carbohydrate sulfotransferase 6 | 2 | 2 | ||||||||
MIRT696347 | SLC35D2 | solute carrier family 35 member D2 | 2 | 2 | ||||||||
MIRT700480 | PUM1 | pumilio RNA binding family member 1 | 2 | 2 | ||||||||
MIRT705909 | ADAM9 | ADAM metallopeptidase domain 9 | 2 | 2 | ||||||||
MIRT714076 | FNDC3B | fibronectin type III domain containing 3B | 2 | 2 | ||||||||
MIRT714401 | FBXO31 | F-box protein 31 | 2 | 2 | ||||||||
MIRT716442 | RPS24 | ribosomal protein S24 | 2 | 2 | ||||||||
MIRT718204 | PSMF1 | proteasome inhibitor subunit 1 | 2 | 2 | ||||||||
MIRT721238 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT721271 | SH3D19 | SH3 domain containing 19 | 2 | 2 | ||||||||
MIRT721603 | ZNF484 | zinc finger protein 484 | 2 | 2 | ||||||||
MIRT722916 | COA4 | cytochrome c oxidase assembly factor 4 homolog | 2 | 2 | ||||||||
MIRT723457 | CUL4A | cullin 4A | 2 | 2 | ||||||||
MIRT733813 | KREMEN1 | kringle containing transmembrane protein 1 | 2 | 0 | ||||||||
MIRT733814 | CASK | calcium/calmodulin dependent serine protein kinase | 2 | 0 | ||||||||
MIRT733815 | KLF4 | Kruppel like factor 4 | 2 | 0 | ||||||||
MIRT733816 | BCL2 | BCL2, apoptosis regulator | 2 | 0 | ||||||||
MIRT733817 | PCNA | proliferating cell nuclear antigen | 2 | 0 | ||||||||
MIRT733818 | BAX | BCL2 associated X, apoptosis regulator | 2 | 0 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|